Programmed inhibition of an innate immune receptor via de novo designed transmembrane proteins
Preprint
Abstract
Transmembrane domains of immune complexes transmit precise signals across lipid bilayers. Probing their interactions has the potential to yield mechanistic insights relevant to therapeutic design. However, our capability to generate molecules directed to bind lipid-embedded sites is limited. Here, we demonstrate a computational strategy to design polypeptides targeting Toll-like receptor 4 (TLR4), a mediator of inflammatory signaling, directly within membranes. TLR4 poses a formidable molecular recognition challenge, as its transmembrane domain is largely apolar, lacks a defined sequence motif, and exhibits an underdetermined structure–function relationship. One synthetic protein binds TLR4’s transmembrane domain and antagonizes NFκB signaling in human cells, proving that precise transmembrane domain interactions are essential for cross-membrane conformational coupling. This work refines design principles for encoding stable interactions in cellular membranes and expands the range of lipid-embedded mechanisms accessible to probe with computationally derived molecules.Keywords
This publication has 79 references indexed in Scilit:
- De novo-designed transmembrane proteins bind and regulate a cytokine receptorNature Chemical Biology, 2024
- Computational design of BclxL inhibitors that target transmembrane domain interactionsProceedings of the National Academy of Sciences, 2023
- Protein Structure Prediction and Design in a Biologically Realistic Implicit MembraneBiophysical Journal, 2020
- Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate themJournal of Biological Chemistry, 2020
- Recent clinical trends in Toll‐like receptor targeting therapeuticsMedicinal Research Reviews, 2018
- De novo designed transmembrane peptides activating the α5β1 integrinProtein Engineering, Design and Selection, 2018
- Spatial structure of TLR4 transmembrane domain in bicelles provides the insight into the receptor activation mechanismScientific Reports, 2017
- The Ectodomain of the Toll-like Receptor 4 Prevents Constitutive Receptor ActivationJournal of Biological Chemistry, 2011
- Different functional role of domain boundaries of Toll-like receptor 4Biochemical and Biophysical Research Communications, 2009
- Computational Design of Peptides That Target Transmembrane HelicesScience, 2007